344 related articles for article (PubMed ID: 24833898)
1. Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.
Baker CL; Zou KH; Su J
Int J Chron Obstruct Pulmon Dis; 2014; 9():431-9. PubMed ID: 24833898
[TBL] [Abstract][Full Text] [Related]
2. Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.
Celli BR; Navaie M; Xu Z; Cho-Reyes S; Dembek C; Gilmer TP
Int J Chron Obstruct Pulmon Dis; 2019; 14():1019-1031. PubMed ID: 31190787
[No Abstract] [Full Text] [Related]
3. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.
Wurst KE; St Laurent S; Mullerova H; Davis KJ
Int J Chron Obstruct Pulmon Dis; 2014; 9():1021-31. PubMed ID: 25285002
[TBL] [Abstract][Full Text] [Related]
4. Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan.
Xu Q; Laxa SS; Serna O; Sansgiry SS
Am Health Drug Benefits; 2020 Feb; 13(1):32-42. PubMed ID: 32165997
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of early medication use for COPD: a population-based cohort study.
Falk J; Dik N; Bugden S
Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
[TBL] [Abstract][Full Text] [Related]
6. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
[TBL] [Abstract][Full Text] [Related]
7. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
8. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States.
Diette GB; Dalal AA; D'Souza AO; Lunacsek OE; Nagar SP
Int J Chron Obstruct Pulmon Dis; 2015; 10():415-22. PubMed ID: 25759574
[TBL] [Abstract][Full Text] [Related]
10. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
[TBL] [Abstract][Full Text] [Related]
11. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
Foda HD; Brehm A; Goldsteen K; Edelman NH
Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
[TBL] [Abstract][Full Text] [Related]
12. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.
Salinas GD; Williamson JC; Kalhan R; Thomashow B; Scheckermann JL; Walsh J; Abdolrasulnia M; Foster JA
Int J Chron Obstruct Pulmon Dis; 2011; 6():171-9. PubMed ID: 21468169
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
Ding B; Small M; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
[TBL] [Abstract][Full Text] [Related]
14. Adherence to a COPD treatment guideline among patients in Hong Kong.
Chan KP; Ko FW; Chan HS; Wong ML; Mok TY; Choo KL; Hui DS
Int J Chron Obstruct Pulmon Dis; 2017; 12():3371-3379. PubMed ID: 29238182
[TBL] [Abstract][Full Text] [Related]
15. Trends and Factors Associated with Nebulized Therapy Prescription in Older Adults with Chronic Obstructive Pulmonary Disease from 2008 to 2015.
Singh M; Duarte AG; Hsu ES; Kuo YF; Sharma G
J Aerosol Med Pulm Drug Deliv; 2020 Jun; 33(3):161-169. PubMed ID: 32017642
[No Abstract] [Full Text] [Related]
16. Development and validation of a drug adherence index for COPD.
Bengtson LGS; Bancroft T; Schilling C; Buikema AR; Stanford RH
J Manag Care Spec Pharm; 2021 Feb; 27(2):198-209. PubMed ID: 33506734
[No Abstract] [Full Text] [Related]
17. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; RamÃrez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
18. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Lee JK; Rhee CK; Kim K; Ra SW; Lee JH; Jung KS; Yoo KH; Kim YI; Kim DK
Int J Chron Obstruct Pulmon Dis; 2019; 14():2639-2647. PubMed ID: 31819397
[TBL] [Abstract][Full Text] [Related]
19. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
20. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
Punekar YS; Landis SH; Wurst K; Le H
Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
